Ganglioneuroblastoma clinical trials

Explore recruiting ganglioneuroblastoma clinical trials.

Recruiting ganglioneuroblastoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ganglioneuroblastoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase II Study of Naxitamab Added to Induction Therapy for Subjects with Newly Diagnosed High-Risk Neuroblastoma

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Ganglioneuroblastoma trials by city

Ganglioneuroblastoma in Toronto Ganglioneuroblastoma in Vancouver Ganglioneuroblastoma in Montreal Ganglioneuroblastoma in Calgary Ganglioneuroblastoma in Edmonton Ganglioneuroblastoma in Ottawa Ganglioneuroblastoma in Winnipeg Ganglioneuroblastoma in Quebec City Ganglioneuroblastoma in Hamilton Ganglioneuroblastoma in Kitchener Ganglioneuroblastoma in London Ganglioneuroblastoma in Halifax Ganglioneuroblastoma in New York Ganglioneuroblastoma in Los Angeles Ganglioneuroblastoma in Chicago Ganglioneuroblastoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease